The translocation of nuclear molecules during inflammation and cell death

Antioxidants and Redox Signaling

Volumn 20, Issue 7, 2014, Pages 1117-1125

  Pisetsky, David S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL DEATH; CELL NUCLEUS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; NUCLEAR PROTEINS;

EID: 84894099489     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5143     Document Type: Review

References (66)

1. Allam R, Scherbaum CR, Darispudi MN, Mulay SR, Hagele H, Lichtnekert J, Hagemann JH, Rupanagudi KV, Ryu M, Schwarzwenberger C, Hohenstein B, Hugo C, Uhl B, Reichel CA, Krombach F, Monestier M, Liapis H, Moreth K, Schaefer L, and Anders H-J. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 23: 1-14, 2012.
2. Andersson U, Wang H, Palmblad K, Aveberger A-C, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, and Tracey KJ. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192: 565-570, 2000.
3. Andersson U and Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29: 139-162, 2011.
4. Ardoin SP and Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res Ther 10: 218, 2008.
5. Barton GM, Kagan JC, and Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7: 49-56, 2006.
6. Barton GM and Kagan JC. A cell biological view of Toll-like receptor function: Regulation through compartmentalization. Nat Rev Immunol 9: 535-542, 2009.
7. Bell CW, Jiang W, Reich CF 3rd, and Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291: C1318-C1325, 2006.
8. Beyer C, Stearns NA, Giessl A, Distler JH, Schett G, and Pisetsky D. The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun 18: 727-737, 2012.
9. Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81: 1-5, 2007.
10. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, and Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22: 5551-5560, 2003.
11. Chen GY and Nuñez G. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 10: 826-837, 2010.
12. Choi JJ, Reich CF 3rd, and Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 115: 55-62, 2005.
13. Coll RC and O'Neill LA. New insights into the regulation of signaling by toll-like receptors and nod-like receptors. J Innate Immun 2: 406-421, 2010.
14. Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Gob C, Anz D, Simanski M, Glaser R, Harder J, Hornung V, Gallo RL, Ruzicka T, Besch R, and Schauber J. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 3: 82ra38, 2011.
15. Fink SL and Cookson BT. Apoptosis, pyroptosis and necrosis: Mechanistic description of dead and dying eukaryotic cells. Infect Immun 73: 1907-1916, 2005.
16. Galluzzi L and Kroemer G. Necroptosis: A specialized pathway of programmed necrosis. Cell 135: 1161-1163, 2008.
17. Harris HE, Andersson U, and Pisetsky DS. HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8: 195-202, 2012.
18. Hirsiger S, Simmens H-P, Werner CML, Wanner GA, and Rittirsch D. Danger signals activating the immune response after trauma. Mediators Inflamm 2012: 315941, 2012.
19. Holdenrieder S and Stieber P. Clinical use of circulating nucleosomes. Crit Rev Clin Lab Sci 46: 1-24, 2009.
20. Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, and Harris HE. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals. J Leukoc Biol 86: 655-662, 2009.
21. Hreggvidsdottir HS, Lundberg AM, Aveberger AC, Klevenvall L, Andersson U, and Harris HE. HMGB1-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol Med 18: 224-230, 2012.
22. Huang H, Evankovich J, Yan W, Nace G, Zhang L, Ross M, Liao X, Billiar T, Xu J, Esmon CT, and Tsung A. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 54: 999-1008, 2011.
23. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, and Mehal WZ. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 119: 305-314, 2009.
24. Ito I, Fukazawa J and Yoshia M. Post-Translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 282: 16336-16344, 2007.
25. Jiang N, Reich CF 3rd, and Pisetsky DS. Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells. Blood 102: 2243-2250, 2003.
26. Jiang N, Reich CF 3rd, Monestier M, and Pisetsky DS. The expression of plasma nucleosomes in mice undergoing in vivo apoptosis. Clin Immunol 106: 139-147, 2003.
27. Jiang N and Pisetsky DS. The effect of dexamethasone on the generation of plasma DNA from dead and dying cells. Am J Pathol 164: 1751-1759, 2004.
28. Jiang W, Reich CF 3rd, and Pisetsky DS. Mechanisms of activation of the RAW 264.7 macrophage cell line by transfected mammalian DNA. Cell Immunol 229: 31-40, 2004.
29. Jiang W, Bell CW, and Pisetsky DS. The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol 178: 6495-6503, 2007.
30. Kabbe K and Saleh M. Cell death in the host response to infection. Cell Death Differ 15: 1339-1349, 2008.
31. Kawal T and Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650, 2011.
32. Kawasaki T, Kawai T, and Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev 243: 61-73, 2011.
33. Kazama H, Ricci JE, Herndon HM, Hoppe G, Green DR, and Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of highmobility group box-1 protein. Immunity 29: 21-32, 2008.
34. Khorasanizadeh S. The nucleosome: From genomic organization to genomic regulation. Cell 116: 259-272, 2004.
35. Kono H and Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289, 2008.
36. Lam NYL, Rainer TH, Chan LYS, Joynt GM, and Lo YMD. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 49: 1286-1291, 2003.
37. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y-H, Homey B, Cao W, Wang Y-H, Su B, Nestle FO, Zal T, Mellman I, Schröder J-M, Liu Y-J, and Gilliet M. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-571, 2007.
38. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu Y-J, and Gilliet M. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3: 1-11, 2011.
39. Lee J, Sohn JW, Zhang Y, Leong KW, Pisetsky D, and Sullenger BA. Nucleic acid-binding polymers as antiinflammatory agents. Proc Natl Acad Sci U S A 108: 14055-14060, 2011.
40. Lin T, Sammy F, Yang H, Thundivalappil S, Hellman J, Trace KJ, and Warren HS. Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation. J Immunol 189: 2017-2022, 2012.
41. Lui YYN and Lo YMD. Circulating DNA in plasma and serum: Biology, preanalytical issues and diagnostic applications. Clin Chem Lab Med 40: 962-968, 2002.
42. Pemberton AD, Brown JK, and Inglis NF. Proteomic identification of interactions between histones and plasma proteins: Implications for cytoprotection. Proteomics 10: 1484-1493, 2010.
43. Pisetsky D. Cell death in the pathogenesis of immune-mediated diseases: The role of HMGB1 and DAMP-PAMP complexes. Swiss Med Wkly 141: W13256, 2011.
44. Pisetsky DS and Ullal AJ. The blood nucleome in the pathogenesis of SLE. Autoimmun Rev 10: 35-37, 2010.
45. Rouhiainen A, Imal S, Rauvala H, and Parkkinen J. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost 84: 1087-1094, 2000.
46. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, and Rauvala H. Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (Amphoterin). J Leukoc Biol 81: 1-10, 2007.
47. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Müller S, Iannacone M, Traversari C, Binachi ME, and Manfredi AA. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 5: 825-830, 2004.
48. Rubartelli A and Lotze MT. Inside, outside, upside down: Damage-Associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 28: 429-436, 2007.
49. Scaffidi P, Mistell T, and Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002.
50. Schwarzenbach H, Hoon DSB, and Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11: 426-437, 2011.
51. Sha Y, Zmijewski J, Xu Z, and Abraham E. HMGB1 developes enhanced proinflammatory activity by binding to cytokines. J Immunol 180: 2531-2537, 2008.
52. Takaoka A, Wang ZC, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, and Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-506, 2007.
53. Theofilopoulos AN, Kono DH, Beutler B, and Baccala R. Intracellular nucleic acid sensors and autoimmunity. J Interferon Cytokine Res 31: 867-886, 2011.
54. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, and Coyle AJ. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8: 474-477, 2007.
55. Tran TT, Groben P, and Pisetsky DS. The release of DNA into the plasma of mice following hepatic cell death by apoptosis and necrosis. Biomarkers 13: 184-200, 2008.
56. Ueda T and Yoshida M. HMGB proteins and transcriptional regulation. Biochim Biophys Acta 1799: 114-118, 2010.
57. Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, and Voll RE. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med 205: 3007-3018, 2008.
58. Valouev A, Johnson SM, Boyd SD, Smith CL, Fire AZ, and Sidow A. Determinants of nucleosome organization in primary human cells. Nature 474: 516-522, 2012.
59. Venereau E, Casalgrandi M, Schiradldi M, Antoine DJ, Cattaneo A, De Marchis F, Liu J, Antonelli A, Preti A, Raeli L, Shams SS, Yang H, Varani L, Andersson U, Tracey KJ, Bachi A, Uguccioni M, and Bianchi ME. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine disease. J Exp Med 209: 1519-1528, 2012.
60. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manoque KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, and Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
61. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, and Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med 15: 1318-1321, 2009.
62. Xu J, Zhang X, Monestier M, Esmon NL, and Esmon CT. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 187: 2626-2631, 2011.
63. Yang H, Lündback P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, and Antoine DJ. Redox modification of cysteine residues regulates the cytokine activity of HMGB1. Mol Med 18: 250-259, 2012.
64. Youn JH and Shin J-S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177: 7889-7897, 2006.
65. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, and Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107, 2010.
66. Zimmerman K, Vö lkel D, Pable S, Lindner T, Kramberger F, Bahrami S, and Scheiflinger F. Native versus recombinant high-mobility group B1 proteins: Functional activity in vitro. Inflammation 28: 221-229, 2004.